Ethicon Announces FDA Approval For SURGICEL Powder Absorbable Hemostat

Go back to Ethicon Announces FDA Approval For SURGICEL Powder Absorbable Hemostat
Johnson & Johnson (NYSE: JNJ) Delayed: 257.77 --0 (-0%)
Previous Close $257.77    52 Week High $126.07 
Open $257.77    52 Week Low $94.28 
Day High $257.77    P/E 53.59 
Day Low $257.77    EPS $4.81 
Volume 9,483